NCT05011773
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +20 more
- Locations
-
- John Radcliffe Hospital Oxford, Oxfordshire, United Kingdom
Clinical trial condition
Shy-Drager Syndrome
Explore clinical trials studying Shy-Drager Syndrome. Study availability and eligibility vary by location and protocol.
28 public trials
11 recruiting studies
Shy-Drager Syndrome trial results
Completed
PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)
NCT02035761
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +11 more
- Locations
-
- University of Michigan - Department of Neurology Ann Arbor, Michigan, United States
Completed
The Autonomic Nervous System and Obesity
NCT00179023
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Body Weight, +19 more
- Locations
-
- Vanderbilt University Nashville, Tennessee, United States
NCT00223717
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +13 more
- Locations
-
- Vanderbilt University Nashville, Tennessee, United States
NCT00004478
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +20 more
- Locations
-
- New York University School of Medicine New York, United States
Active, Not Recruiting
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)
NCT05792332
- Conditions
- Atypical Parkinsonism, Autonomic Nervous System Diseases, Basal Ganglia Diseases, +14 more
- Locations
-
- Azienda Ospedaliera Universitaria Gaetano Martino Messina, Italy
- Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Italy
- Fondazione IRCCS Istituto Neurologico Nazionale Casmiro Mondino Pavia, Italy
- IRCCS Neuromed Pozzilli, Italy
Active, Not Recruiting
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +11 more
- Locations
-
- Movement Disorders Center of Arizona Scottsdale, Arizona, United States
- The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States
- UC San Diego Movement Disorder Center La Jolla, California, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
Active, Not Recruiting
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)
NCT05698017
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +12 more
- Locations
-
- Tel-Aviv Sourasky Medical Center (Ichilov) Tel Aviv, Israel